Current Protein Identity：Q9BQB6
New Search
Difference tags compare only the current result set; every original PDB and assembly record remains separate.
Related-Structure Differences
Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.
| PDB Entry | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Experimental Method | Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 6WV3 Human VKOR with warfarin Deposited 2020-05-05 | Assembly 1 Insufficient information Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
3–155（153 aa）
Fragment：GPF (UNP residues 1-144) + VKOR + GFP (UNP residues 146-231)
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 3 SWF S-WARFARIN × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
LIPIDIC CUBIC PHASE；pH 6.5；295 K；37% PEG400, 0.1 M MES, pH 6.5
|
Resolution 2.20 Å R-free 0.223 |
| 6WV4 Human VKOR C43S with warfarin Deposited 2020-05-05 | Assembly 1 Insufficient information Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
3–155（153 aa）
Fragment：GPF (UNP residues 1-144) + VKOR + GFP (UNP residues 146-231)
|
Mutation：C43S Non-standard monomer：Yes (specific site not provided by mmCIF) | SWF S-WARFARIN × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
LIPIDIC CUBIC PHASE；pH 6.5；295 K；25-33% PEG400, 185-220 mM potassium formate, 0.1 M MES, pH 6.5
|
Resolution 3.01 Å R-free 0.292 |
| 6WV5 Human VKOR C43S mutant with vitamin K1 epoxide Deposited 2020-05-05 | Assembly 1 Insufficient information Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
3–155（153 aa）
Fragment：GPF (UNP residues 1-144) + VKOR + GFP (UNP residues 146-231)
|
Mutation：C43S Non-standard monomer：Yes (specific site not provided by mmCIF) | UAV (2R,3R)-2-hydroxy-3-methyl-2-[(2E,7S)-3,7,11,15-tetramethylhexadec-2-en-1-yl]-2,3-dihydronaphthalene-1,4-dione × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
LIPIDIC CUBIC PHASE；pH 6.5；295 K；25% PEG400, 0.1 M ammonium citrate dibasic, 0.1 M MES, pH 6.5
|
Resolution 2.80 Å R-free 0.270 |
| 6WV6 Human VKOR with phenindione Deposited 2020-05-05 | Assembly 1 Insufficient information Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
3–155（153 aa）
Fragment：GPF (UNP residues 1-144) + VKOR + GFP (UNP residues 146-231)
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 2 UAS Phenindione × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
LIPIDIC CUBIC PHASE；pH 6.5；295 K；34% PEG400, 80 mM lithium sulfate, 0.1 M MES, pH 6.5
|
Resolution 2.70 Å R-free 0.268 |
| 6WV7 Human VKOR with Chlorophacinone Deposited 2020-05-05 | Assembly 1 Insufficient information Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
3–155（153 aa）
Fragment：GPF (UNP residues 1-144) + VKOR + GFP (UNP residues 146-231)
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | UAJ Chlorophacinone × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
LIPIDIC CUBIC PHASE；pH 6.5；295 K；33% PEG400, 5% DMSO, 0.1 M sodium acetate, 0.1 M MES, pH 6.5
|
Resolution 2.48 Å R-free 0.245 |
| 6WV7 Human VKOR with Chlorophacinone Deposited 2020-05-05 | Assembly 2 Insufficient information Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain B
3–155（153 aa）
Fragment：GPF (UNP residues 1-144) + VKOR + GFP (UNP residues 146-231)
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | UAJ Chlorophacinone × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
LIPIDIC CUBIC PHASE；pH 6.5；295 K；33% PEG400, 5% DMSO, 0.1 M sodium acetate, 0.1 M MES, pH 6.5
|
Resolution 2.48 Å R-free 0.245 |
| 6WVH Human VKOR with Brodifacoum Deposited 2020-05-06 | Assembly 1 Insufficient information Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
3–155（153 aa）
Fragment：GPF (UNP residues 1-144) + VKOR + GFP (UNP residues 146-231)
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | UA7 Brodifacoum × 1 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 2 | X-RAY DIFFRACTION |
X-ray crystallization conditions
LIPIDIC CUBIC PHASE；pH 6.5；295 K；32% PEG400, 0.1 M ammonium acetate, 1% 1,2,3-heptanetriol, 0.1 M MES, pH 6.5
|
Resolution 1.99 Å R-free 0.215 |
| 6WVH Human VKOR with Brodifacoum Deposited 2020-05-06 | Assembly 2 Insufficient information Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain B
3–155（153 aa）
Fragment：GPF (UNP residues 1-144) + VKOR + GFP (UNP residues 146-231)
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | UA7 Brodifacoum × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
LIPIDIC CUBIC PHASE；pH 6.5；295 K；32% PEG400, 0.1 M ammonium acetate, 1% 1,2,3-heptanetriol, 0.1 M MES, pH 6.5
|
Resolution 1.99 Å R-free 0.215 |